Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Capricor Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Capricor Therapeutics Inc
Rating: 0.85108325
Author: Trendlyne DVM scores

about

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

6.28 0.02 (0.32%)

73.16% Fall from 52W High

794.3K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

13.3 / 100

Technically Bearish

20.7 / 100

1Yr Price target upside is 228%

10 analysts

Capricor Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

73.16% Fall from 52W High

SWOT Analysis

Capricor Therapeutics Inc Live Price Chart